You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TARA Sale Disclosure
Shefferman Jesse · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$882.16K
Shefferman Jesse CEO And President
TARA
Protara Therapeutics
TARA
Transaction date
Jun 29, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 2 days later
TARA daily price context
Close on/before transaction
$4.16
Jun 29, 2026
First close after public filing
$4.06
Jul 2, 2026
30-day return after filing
-3.45%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 215,687 shares @ $4.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001213900-26-074238
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$1.29M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protara Therapeutics, Inc. TARA | Gift | Jun 30, 2026 | $0 |
| Protara Therapeutics, Inc. TARA | Gift | Jun 30, 2026 | $0 |
| Protara Therapeutics, Inc. TARA | Gift | Jun 30, 2026 | $0 |
| Protara Therapeutics, Inc. TARA | Gift | Jun 30, 2026 | $0 |
| Protara Therapeutics, Inc. TARA | Exercise | Jun 29, 2026 | $0 |
| Protara Therapeutics, Inc. TARA | Exercise | Jun 29, 2026 | $411.96K |
| Protara Therapeutics, Inc. TARA Current | Sale | Jun 29, 2026 | $882.16K |